MY179706A - Combination pharmaceutical composition and methods of treating and preventing the infectious diseases - Google Patents

Combination pharmaceutical composition and methods of treating and preventing the infectious diseases

Info

Publication number
MY179706A
MY179706A MYPI2013000381A MYPI2013000381A MY179706A MY 179706 A MY179706 A MY 179706A MY PI2013000381 A MYPI2013000381 A MY PI2013000381A MY PI2013000381 A MYPI2013000381 A MY PI2013000381A MY 179706 A MY179706 A MY 179706A
Authority
MY
Malaysia
Prior art keywords
treating
preventing
pharmaceutical composition
methods
infectious diseases
Prior art date
Application number
MYPI2013000381A
Inventor
Sergey Alexandrovich Tarasov
Original Assignee
Epshtein Oleg Lliich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2010133044/15A external-priority patent/RU2516931C2/en
Priority claimed from RU2010133041/15A external-priority patent/RU2010133041A/en
Priority claimed from RU2010133047/15A external-priority patent/RU2517085C2/en
Application filed by Epshtein Oleg Lliich filed Critical Epshtein Oleg Lliich
Publication of MY179706A publication Critical patent/MY179706A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to at least one cytokine and b) an activated-potentiated form of an antibody to at least one receptor, and methods of treating and preventing the infectious diseases, including bacterial infections caused by different infectious agents such as pseudotuberculosis, whooping cough, yersiniosis, pneumonitis of different etiology, and acute and chronic viral infections such as acute respiratory tract infections, influenza of different types, acute viral hepatitis A, B, C and other types of hepatitis, the diseases and conditions caused by HIV or associated with HIV, including AIDS.
MYPI2013000381A 2010-08-06 2011-07-15 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases MY179706A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010133044/15A RU2516931C2 (en) 2010-08-06 2010-08-06 Method and composition for preventing hiv infection, preventing and treating hiv-caused or hiv-associated diseases, including aids
RU2010133041/15A RU2010133041A (en) 2010-08-06 2010-08-06 INTEGRATED MEDICINE AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS
RU2010133047/15A RU2517085C2 (en) 2010-08-06 2010-08-06 Complex medication and method of preventing hiv infection, prevention and treatment of hiv-induced and hiv-associated diseases, including aids

Publications (1)

Publication Number Publication Date
MY179706A true MY179706A (en) 2020-11-11

Family

ID=79170496

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013000381A MY179706A (en) 2010-08-06 2011-07-15 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases

Country Status (1)

Country Link
MY (1) MY179706A (en)

Similar Documents

Publication Publication Date Title
GB201303867D0 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EA026667B9 (en) Pharmaceutical composition for treating hepatitis c virus
PH12014501314A1 (en) Hepatitis b antiviral agents
MY195364A (en) Amide Compounds for the Treatment Of Hiv
MX2014009546A (en) Antiviral compounds with a heterotricycle moiety.
MY190867A (en) ? -d-2'-deoxy-2'-?-fluoro-2'- ? -c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
MY197236A (en) 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
EA201490213A1 (en) BENZOFURANE CONNECTIONS FOR THE TREATMENT OF INFECTIONS BY THE HEPATITIS C VIRUS
WO2015058772A3 (en) Novel hcv culture systems and direct-acting antiviral sensitivity
EP2601967A4 (en) Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids
EA201400235A1 (en) VACCINES AGAINST FLU BASED ON H5
WO2015086738A3 (en) Hiv vaccine
BR112017006117A2 (en) benzofuran analog as ns4b inhibitor
MY179706A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
UA112748C2 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
WO2017011620A3 (en) Methods and compositions related to increasing the fidelity of influenza a virus for vaccine development
UA59589U (en) method for prevention of respiratory diseases of calves of mixed etiology
UA114095U (en) Vaccine inactivated against infectious rhinotracheitis, PARAGRIPLE-3, viral diarrhea and pasteurellosis of pepper "BOVISWAK-3 PAST"
WO2012017327A3 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
UA111703C2 (en) INFLUENCES OF Flu Virus Replication
TR201004187A2 (en) Colds = acute viral rhinitis = influenza and influenza = drug and method developed to limit and terminate the effects of influenza infections.
TH137303B (en) New European PRRSV strain "
WO2013026054A3 (en) Production of infectious rna viruses in yeast